SEC Tracker
Get the app

Veracyte VCYT

Epstein Robert (Director) plans to sell 10,000 VCYT shares, about $416,900

Form
144
Filed
Importance
Routine
  1. Approximate sale date: May 20, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Previously Exercised Stock Options
  4. 10b5-1 plan adopted: Dec 5, 2025

All of Epstein Robert's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Veracyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. GRAIL GRAL public float $1.9B, Jun 30, 2025
  2. BillionToOne BLLN
  3. CareDx CDNA public float $1.0B, Jun 30, 2025
  4. Lumexa Imaging Holdings LMRI
  5. Caris Life Sciences CAI public float $3.9B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.